{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:11:08Z","timestamp":1781712668455,"version":"3.54.5"},"reference-count":32,"publisher":"BMFH Press","issue":"4","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82274493"],"award-info":[{"award-number":["82274493"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81774299"],"award-info":[{"award-number":["81774299"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research Program of Universities in Anhui Province","award":["2023AH050791"],"award-info":[{"award-number":["2023AH050791"]}]},{"name":"Scientific Research Program of the Chinese Society of Ethnomedicine","award":["2020ZY070-410033"],"award-info":[{"award-number":["2020ZY070-410033"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.12938\/bmfh.2025-012","type":"journal-article","created":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T18:07:17Z","timestamp":1749406037000},"page":"279-289","source":"Crossref","is-referenced-by-count":1,"title":["Gandouling improves Wilson\u2019s disease liver fibrosis by modulating intestinal flora: a randomized, double-blind, placebo-controlled trial"],"prefix":"10.12938","volume":"44","author":[{"given":"Yue","family":"PU","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Anhui University of Chinese Medicine,              Shushan District, Hefei City, Anhui Province No. 117 Meishan Road Hefei Anhui 230031,              China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"LI","sequence":"additional","affiliation":[{"name":"Huaibei People\u2019s Hospital, Huaibei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"CHEN","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui University of Chinese Medicine,              Shushan District, Hefei City, Anhui Province No. 117 Meishan Road Hefei Anhui 230031,              China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"MA","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui University of Chinese Medicine,              Shushan District, Hefei City, Anhui Province No. 117 Meishan Road Hefei Anhui 230031,              China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"YE","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui University of Chinese Medicine,              Shushan District, Hefei City, Anhui Province No. 117 Meishan Road Hefei Anhui 230031,              China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxiang","family":"ZHANG","sequence":"additional","affiliation":[{"name":"Lu\u2019an People\u2019s Hospital of Anhui Province, Lu\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"ZHANG","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui University of Chinese Medicine,              Shushan District, Hefei City, Anhui Province No. 117 Meishan Road Hefei Anhui 230031,              China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5076","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Xu              WQ, Wang              RM, Dong              Y, Wu              ZY. 2023.            Pathogenicity of intronic and synonymous variants of ATP7B in Wilson            disease. J Mol Diagn 25:            57\u201367.","DOI":"10.1016\/j.jmoldx.2022.10.002"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tinaz              S, Arora              J, Nalamada              K,                Vives-Rodriguez              A, Sezgin              M, Robakis              D, Patel              A, Constable              RT, Schilsky              ML. 2021.            Structural and functional brain changes in hepatic and neurological            Wilson disease. Brain Imaging Behav 15: 2269\u20132282.","DOI":"10.1007\/s11682-020-00420-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Paternostro              R,                Pfeiffenberger              J, Ferenci              P,                St\u00e4ttermayer              AF, Stauber              RE, Wrba              F, Longerich              T, Lackner              K, Trauner              M, Ferlitsch              A, et            al. 2020. Non-invasive diagnosis of            cirrhosis and long-term disease monitoring by transient elastography in patients with            Wilson disease. Liver Int 40:            894\u2013904.","DOI":"10.1111\/liv.14368"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Day              PL,                Fyffe-Freil              R, Vanderboom              P, Spears              G,                Wangensteen              K, Bornhorst              J, Hassan              S, Jannetto              PJ. 2024.            Iron and copper liver concentrations in Wilson disease.            J Gastrointestin Liver Dis 33:            517\u2013523.","DOI":"10.15403\/jgld-5662"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cz\u0142onkowska              A, Litwin              T, Dusek              P, Ferenci              P, Lutsenko              S, Medici              V, Rybakowski              JK, Weiss              KH, Schilsky              ML. 2018.            Wilson disease. Nat Rev Dis            Primers 4: 21.","DOI":"10.1038\/s41572-018-0018-3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mulligan              C, Bronstein              JM. 2020.            Wilson disease: an overview and approach to management.            Neurol Clin 38: 417\u2013432.","DOI":"10.1016\/j.ncl.2020.01.005"},{"key":"7","unstructured":"7. Tao              Z, Sun              LJ, Wang              F, Jiang              C, Jiang              ZZ, Han              H, Sun              K, Yang              WM, Wang              MX. 2023.            Progress of Chinese and Western medicine research on liver fibrosis in            hepatomegaly nuclear degeneration. Journal of Integrative            Cardiovascular and Cerebrovascular Disease 21:            3380\u20133383 (in Chinese)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Zhang              J, Xie              D, Li              Y, Li              L, Han              H, Zhang              J, Chen              H, Wang              M, Guo              Y. 2018.            Evaluation of efficacy and safety of gandouling plus sodium            dimercaptosulphonate in treatment of patients with neurological Wilson\u2019s disease from            China. J Tradit Chin Med 38:            781\u2013786.","DOI":"10.1016\/S0254-6272(18)30919-1"},{"key":"9","unstructured":"9. Zeng              Y, Li              T, Zhang              J, Ou              YCH, Wang              GW, Xiao              WB. 2024.            Chinese clinical guidelines for the diagnosis and treatment of            hepatolenticular degeneration: the combination of pharmacotherapy and surgical            intervention. International Journal of Neurology and            Neurosurgery 51:          1\u201313."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Cheng              C, Wang              Q, Huang              Y, Xue              Q, Wang              Y, Wu              P, Liao              F, Miao              C. 2023.            Gandouling inhibits hepatic fibrosis in Wilson\u2019s disease through            Wnt-1\/\u03b2-catenin signaling pathway. J            Ethnopharmacol 311: 116445.","DOI":"10.1016\/j.jep.2023.116445"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zhao              C, Chen              J, Tian              L, Wen              Y, Wu              M, Tang              L, Zhou              A, Xie              W, Dong              T. 2024.            Gandouling ameliorates liver injury in Wilson\u2019s disease through the            inhibition of ferroptosis by regulating the HSF1\/HSPB1 pathway.            J Cell Mol Med 28: e70018.","DOI":"10.1111\/jcmm.70018"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Dong              T, Wu              MC, Tang              LL, Jiang              HL, Zhou              P, Kuang              CJ, Tian              LW, Yang              WM. 2021.            GanDouLing promotes proliferation and differentiation of neural stem            cells in the mouse model of Wilson\u2019s disease. Biosci            Rep 41: BSR20202717.","DOI":"10.1042\/BSR20202717"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tian              L, Wu              M, Zhao              C, Wen              Y, Chen              J, Dong              T. 2024.            Gandouling induces GSK3\u03b2 promoter methylation to improve cognitive            impairment in Wilson\u2019s disease. J            Ethnopharmacol 334: 118493.","DOI":"10.1016\/j.jep.2024.118493"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Zhou              B, Yuan              Y, Zhang              S, Guo              C, Li              X, Li              G, Xiong              W, Zeng              Z. 2020.            Intestinal flora and disease mutually shape the regional immune system in            the intestinal tract. Front Immunol 11: 575.","DOI":"10.3389\/fimmu.2020.00575"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yan              M, Man              S, Sun              B, Ma              L, Guo              L, Huang              L, Gao              W. 2023.            Gut liver brain axis in diseases: the implications for therapeutic            interventions. Signal Transduct Target Ther 8: 443.","DOI":"10.1038\/s41392-023-01673-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tilg              H, Adolph              TE, Trauner              M. 2022.            Gut-liver axis: pathophysiological concepts and clinical            implications. Cell Metab 34:            1700\u20131718.","DOI":"10.1016\/j.cmet.2022.09.017"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Liu              S, Yang              X. 2023.            Intestinal flora plays a role in the progression of            hepatitis-cirrhosis-liver cancer. Front Cell Infect            Microbiol 13: 1140126.","DOI":"10.3389\/fcimb.2023.1140126"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Pu              Y, Zhang              J, Peng              N, Li              R, Xie              DJ, Zhang              RX, Sun              LT, Wang              JL, Ye              H. 2023.              <sup>1<\/sup>H NMR-based metabolomic study of striatal injury in rats            with copper-loaded Wilson\u2019s disease by Chinese and Western medicine            intervention. J Pharm Biomed Anal 229:            115355.","DOI":"10.1016\/j.jpba.2023.115355"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Cai              X, Dai              J, Xie              Y, Xu              S, Liu              M. 2024.            Multi-omics study unravels gut microbiota and metabolites alteration in            patients with Wilson\u2019s disease. Sci Rep 14: 21025.","DOI":"10.1038\/s41598-024-71740-5"},{"key":"20","unstructured":"20. Neurogenetics            Group, Neurology Branch, Chinese Medical Association. 2021.            Chinese Guidelines for the Diagnosis and Treatment of Hepatolenticular            Degeneration 2021. Chin J Neurol 54:            310\u2013319 (in Chinese)."},{"key":"21","unstructured":"21. Xu              L, Liu              P, Shen              X, Wu              Y, Ping              J. 2019.            Guidelines for the Diagnosis and Treatment of Liver Fibrosis by Combining            Traditional Chinese and Western Medicine (2019 Edition). Chinese            J Integrated Traditional and Western Med 39:            1286\u20131295 (in Chinese)."},{"key":"22","unstructured":"22. Neurogenetics            Group of the Neurology Section of the Chinese Medical Association. 2021. Guidelines for the diagnosis and treatment of            hepatomegaly in China 2021. Chin J Neurol 54: 310\u2013319."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yang              X, Li              Q, Liu              W, Zong              C, Wei              L, Shi              Y, Han              Z. 2023.            Author correction: Mesenchymal stromal cells in hepatic            fibrosis\/cirrhosis: from pathogenesis to treatment. Cell Mol            Immunol 20: 687\u2013688.","DOI":"10.1038\/s41423-023-01010-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Soca\u0142a              K,                Doboszewska              U, Szopa              A, Serefko              A, W\u0142odarczyk              M, Zieli\u0144ska              A, Poleszak              E, Fichna              J, Wla\u017a              P. 2021.            The role of microbiota-gut-brain axis in neuropsychiatric and            neurological disorders. Pharmacol Res 172: 105840.","DOI":"10.1016\/j.phrs.2021.105840"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Guan              H, Zhang              X, Kuang              M, Yu              J. 2022.            The gut-liver axis in immune remodeling of hepatic            cirrhosis. Front Immunol 13:            946628.","DOI":"10.3389\/fimmu.2022.946628"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tan              Y, Li              Y, Zhou              F, Guo              J, Wang              T, Shi              Y, Yang              Y, Lu              J, Pei              G. 2020.            Administration of a mixture of triterpenoids from yeyachun and phenolic            acids from danshen ameliorates carbon tetrachloride-induced liver fibrosis in mice by            the regulation of intestinal flora. J Pharmacol            Sci 143: 165\u2013175.","DOI":"10.1016\/j.jphs.2020.04.007"},{"key":"27","unstructured":"27. Qi              Y, Chen              SN. 2024.            Research progress on mechanism of emodin improving intestinal            barrier. Chinese J Traditional Chinese Med 42: 103\u2013108."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. He              X, Liang              J, Li              X, Wang              Y, Zhang              X, Chen              D, Wu              L, Wang              S. 2024.            Dahuang zhechong pill ameliorates hepatic fibrosis by regulating gut            microbiota and metabolites. J Ethnopharmacol 321: 117402.","DOI":"10.1016\/j.jep.2023.117402"},{"key":"29","unstructured":"29. Ding              X, Zhuang              LH, Li              SW, Chen              SY, Guo              J, Lan              T. 2023.            Berberine ameliorates liver fibrosis by inhibition of intestinaI            inflammation and mucosa barrier damage. Chinese J Traditional            Chinese Med 42: 154\u2013159, 271\u2013273."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ghiamati Yazdi              F,                Soleimanian-Zad              S, van den                Worm              E, Folkerts              G. 2019.            Turmeric extract: potential use as a prebiotic and anti-inflammatory            compound? Plant Foods Hum Nutr 74:            293\u2013299.","DOI":"10.1007\/s11130-019-00733-x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Chashmniam              S, Mirhafez              SR, Dehabeh              M, Hariri              M, Azimi                Nezhad              M, Nobakht M                Gh              BF, Gh              BF. 2019.            A pilot study of the effect of phospholipid curcumin on serum metabolomic            profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind,            placebo-controlled trial. Eur J Clin Nutr 73: 1224\u20131235.","DOI":"10.1038\/s41430-018-0386-5"},{"key":"32","unstructured":"32. Sun              ZZ, Fang              X, Jin              S, Liu              KW, Fan              JW, Wang              S. 2022.            A study on the treatment of hepatolenticular degeneration from the            perspective of intestines. Zhejiang Journal of Traditional            Chinese Medicine 57:          474\u2013476."}],"container-title":["Bioscience of Microbiota, Food and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bmfh\/44\/4\/44_2025-012\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T04:39:12Z","timestamp":1759552752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bmfh\/44\/4\/44_2025-012\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.12938\/bmfh.2025-012","relation":{},"ISSN":["2186-3342"],"issn-type":[{"value":"2186-3342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2025-012"}}